Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Mar 16, 2022
Wednesday Mar 16, 2022
touchMDT for touchIMMUNOLOGY
Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.
The multidisciplinary team
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.